Clinical trial
Genetic Analysis of Patients With Pseudoxanthoma Elasticum (PXE)
NCT00341419 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Analysis of Patients With Pseudoxanthoma Elasticum (PXE)
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 16, 2005
- Completion date
- May 14, 2013
- Enrollment
- 188 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.